Blood Management Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Accessories, Reagents & Kits, Software), By Component (Whole Blood, Red Blood Cells, Plasma), By End User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs), By Region and Competition, 2020-2030F

Market Overview

The Global Blood Management Market, valued at USD 13.62 Billion in 2024, is projected to experience a CAGR of 6.90% to reach USD 20.33 Billion by 2030. The global blood management market encompasses the comprehensive set of processes and technologies involved in ensuring a safe, adequate, and efficient blood supply from donor recruitment and collection to processing, testing, storage, and transfusion, including advanced patient blood management strategies. Key drivers supporting market expansion include the increasing incidence of chronic diseases requiring transfusions, a rising volume of surgical procedures worldwide, and the growing elderly population predisposed to conditions necessitating blood products. According to the World Health Organization, in 2023, approximately 118.5 million blood donations were collected globally, underscoring the consistent demand for blood and its components.

However, a significant challenge impeding market growth is the consistent need to maintain a sufficient and safe blood supply amidst evolving donor demographics and stringent regulatory requirements. Sustaining robust donor recruitment and retention programs remains critical, especially given fluctuations in donor availability and the complex logistics of blood component inventory management. This ongoing effort is essential to mitigate potential supply shortages and ensure timely access to life-saving transfusions globally.

Key Market Drivers

The rising prevalence of chronic diseases and blood disorders profoundly drives demand within the global blood management market. Conditions such as sickle cell disease, thalassemia, and various cancers necessitate frequent transfusions and specialized blood products for patient survival and improved quality of life. For example, according to Frontiers in Public Health, August 27, 2024, "Sickle cell disease: a comparative perspective on global and national initiatives," approximately 300,000 infants are born annually with Sickle Cell Disease globally, primarily in sub-Saharan Africa, India, and the Middle East, establishing a continuous requirement for blood components. This pervasive need creates an expanding base for the blood management sector.

Simultaneously, advancements in blood management technologies and diagnostics are revolutionizing the market by enhancing the safety, efficiency, and accessibility of blood-related services. A key development includes the FDA's approval on August 21, 2024, for Epic Systems Corporation's Blood Product Administration Module (BPAM 4-2023), a software using barcode technology for verifying patient and blood product identification during transfusions, as noted in the FDA's "2024 Biological Device Application Approvals. " These technological improvements streamline operations and mitigate errors. The constant demand is further emphasized by the widespread impact of anemia. According to the World Health Organization Global Anemia Estimates, 2021 Edition, anemia affected 30% of non-pregnant women and 37% of pregnant women aged 15-49 globally, representing a substantial patient population reliant on effective blood management interventions. This persistent need, alongside technological progress, propels the market towards sustained growth and improved patient outcomes worldwide.

Download Free Sample Report

Key Market Challenges

A critical challenge impeding the growth of the global blood management market stems from the consistent need to maintain a sufficient and safe blood supply. This challenge is exacerbated by evolving donor demographics and increasingly stringent regulatory requirements, directly impacting the ability of blood establishments to sustain robust donor recruitment and retention programs. The fluctuations in donor availability necessitate significant operational investments in outreach and educational initiatives, diverting resources that could otherwise be allocated to market expansion or technological advancements.

The difficulty in consistently securing adequate blood components directly constrains the potential for market growth. For example, according to AABB, whole blood collections for allogeneic donations declined by 2.7% to 9.57 million units in 2023, while outdated units of whole blood or red blood cells increased by 13.8% from 2021 to 2023. This persistent struggle in maintaining collection volumes and managing component viability translates into reduced availability of blood products for transfusions. Consequently, the market faces limitations in scaling operations and meeting the rising global demand for blood and its components, thereby restricting overall expansion within the blood management sector.

Key Market Trends

The shift towards personalized blood management strategies represents a significant evolution in patient care, moving beyond standardized transfusion protocols to tailored interventions based on individual patient needs. This approach focuses on optimizing a patient's own blood health, minimizing unnecessary transfusions, and thereby reducing associated risks such as infections and adverse reactions. For instance, according to an AABB review of current advances in 2024, treating iron deficiency anemia with intravenous iron significantly reduced postoperative red blood cell transfusions by 70%, improving patient outcomes. This trend influences the market by driving demand for advanced diagnostic tools to assess patient-specific factors like anemia and coagulation status, along with pharmacological alternatives to blood products. The World Health Organization released new guidance in March 2025, outlining a framework to implement personalized blood management policies at national and institutional levels, which underscores the global commitment to these patient-centric practices.

The integration of digital and AI-powered blood management platforms is also profoundly shaping the market by enhancing operational efficiency and decision-making across the blood supply chain. These platforms leverage artificial intelligence and advanced analytics for more accurate blood demand forecasting, optimized inventory management, and improved donor matching. According to an AABB News article from August 2024 on AI and data sciences in blood banking, an AI-based blood utilization calculator implemented at West Virginia University achieved the target hemoglobin value in over 96% of prescribed transfusions during its testing phase. This capability allows for more proactive management of blood resources, minimizing waste and ensuring timely availability of specific blood components. Furthermore, an artificial intelligence model developed by Emory University researchers to predict blood transfusion needs in intensive care unit patients, as reported by America's Blood Centers in February 2025, demonstrated exceptional performance in anticipating transfusion requirements within a 24-hour window. This technological advancement supports clinicians with reliable decision support, leading to enhanced patient safety and resource allocation.

Segmental Insights

The Whole Blood segment is experiencing rapid growth in the Global Blood Management Market, primarily driven by increasing demand for transfusions during surgical procedures and a rising incidence of trauma and accidents globally. This growth is further fueled by the expanding prevalence of blood-related disorders and chronic medical conditions that necessitate regular blood transfusions. The continuous efforts by regulatory bodies to establish stringent screening and testing protocols enhance the safety and reliability of whole blood products, thereby fostering confidence and broader adoption in clinical practice. The critical role of whole blood in managing emergencies and its widespread applicability contribute significantly to this accelerated expansion.

Regional Insights

North America dominates the global blood management market owing to its robust healthcare infrastructure and continuous technological advancements in blood processing, screening, and related devices. The region benefits from a high prevalence of chronic diseases and a significant number of surgical procedures, driving consistent demand for blood and its components. Furthermore, stringent regulatory oversight from bodies like the U. S. Food and Drug Administration (FDA) and adherence to comprehensive standards set by organizations such as the American Association of Blood Banks (AABB) ensure high safety and quality in blood collection, processing, and transfusion practices. These factors, coupled with ongoing research and development investments, solidify North America's leading position.

Recent Developments

• In December 2024, Humacyte Global, Inc., a biotechnology company, obtained FDA approval for Symvess. This product is an off-the-shelf, bioengineered blood vessel implant intended for trauma patients. The approval marked a significant breakthrough in blood-related medical interventions by providing an alternative to traditional methods such as vein harvesting or synthetic grafts. This development offers a safer and readily available option for urgent medical needs within the global blood management sector.

• In November 2024, Terumo Blood and Cell Technologies (Terumo BCT) announced the establishment of its new Global Therapy Innovations business unit. This unit was created to unify disease expertise throughout the patient care continuum, from cell collection to the manufacturing and delivery of therapies. The initiative aimed to optimize solutions across various blood and cell therapies, utilizing platforms such as the Spectra Optia™ and Quantum Flex™ systems to enhance patient access and treatment outcomes within the global blood management market.

• In October 2024, Terumo Blood and Cell Technologies (Terumo BCT), a key participant in blood management systems, launched the Reveos™ Automated Blood Processing System in the United States. This new product was designed to assist blood centers in meeting their platelet and blood supply requirements while simultaneously enhancing staff productivity. The system aimed to streamline the processing of blood components, directly contributing to more efficient operations within the global blood management market and ensuring the availability of essential blood products for patients.

• In March 2024, Becton, Dickinson and Company (BD), a global medical technology firm, introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This new blood collection device integrated RightGauge technology, which was developed to improve the accuracy and efficiency of the blood collection process. The innovation aimed to minimize patient discomfort during procedures, reflecting advancements in blood collection devices that are vital for safe and effective blood management practices worldwide.

Key Market Players

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B Braun Melsungen AG
• bioMérieux Inc.
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• F. Hoffmann-La Roche Ltd.

Report Scope:

In this report, the Global Blood Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Management Market, By Product:

o   Instruments

o   Accessories

o   Reagents & Kits

o   Software

• Blood Management Market, By Component:

o   Whole Blood

o   Red Blood Cells

o   Plasma

• Blood Management Market, By End User:

o   Blood Banks

o   Hospitals

o   Diagnostic Clinics

o   Pathology Labs

• Blood Management Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Blood Management Market.

Available Customizations:

Global Blood Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Blood Management Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]